4/7
07:48 am
agen
Agenus (AGEN) was upgraded by Zacks Research from "hold" to "strong-buy".
Medium
Report
Agenus (AGEN) was upgraded by Zacks Research from "hold" to "strong-buy".
4/6
01:06 am
agen
High
Report
4/3
08:02 pm
agen
Has Agenus (AGEN) Outpaced Other Medical Stocks This Year? [Yahoo! Finance]
High
Report
Has Agenus (AGEN) Outpaced Other Medical Stocks This Year? [Yahoo! Finance]
4/3
01:39 pm
agen
All You Need to Know About Agenus (AGEN) Rating Upgrade to Strong Buy [Yahoo! Finance]
High
Report
All You Need to Know About Agenus (AGEN) Rating Upgrade to Strong Buy [Yahoo! Finance]
4/3
07:30 am
agen
Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026
High
Report
Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026
4/1
08:24 am
agen
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer [Yahoo! Finance]
Low
Report
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer [Yahoo! Finance]
4/1
07:30 am
agen
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer
Low
Report
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer
4/1
02:04 am
agen
Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript [Seeking Alpha]
Low
Report
Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript [Seeking Alpha]
3/31
06:16 pm
agen
Agenus AGM: Bot/Bal Combo Targets “Cold” MSS Colorectal Cancer as Phase III BATMAN Trial Launches [Yahoo! Finance]
Low
Report
Agenus AGM: Bot/Bal Combo Targets “Cold” MSS Colorectal Cancer as Phase III BATMAN Trial Launches [Yahoo! Finance]
3/31
11:03 am
agen
MiNK Therapeutics, Inc. (INKT) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Neutral
Report
MiNK Therapeutics, Inc. (INKT) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/29
01:09 am
agen
Medium
Report
3/26
05:11 pm
agen
Agenus to Host March 2026 Stakeholder Webcast Harnessing the Immune System to Advance BOT + BAL Across Tumor Types and Expand Patient Access [Yahoo! Finance]
Low
Report
Agenus to Host March 2026 Stakeholder Webcast Harnessing the Immune System to Advance BOT + BAL Across Tumor Types and Expand Patient Access [Yahoo! Finance]
3/26
04:52 pm
agen
Agenus to Host March 2026 Stakeholder Webcast Harnessing the Immune System to Advance BOT + BAL Across Tumor Types and Expand Patient Access
Low
Report
Agenus to Host March 2026 Stakeholder Webcast Harnessing the Immune System to Advance BOT + BAL Across Tumor Types and Expand Patient Access
3/17
04:40 pm
agen
Agenus Announces Upcoming AACR 2026 Presentation Evaluating Botensilimab Plus Balstilimab in First-Line MSS Metastatic Colorectal Cancer
Medium
Report
Agenus Announces Upcoming AACR 2026 Presentation Evaluating Botensilimab Plus Balstilimab in First-Line MSS Metastatic Colorectal Cancer
3/16
08:06 am
agen
Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized [Yahoo! Finance]
Medium
Report
Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized [Yahoo! Finance]
3/16
07:30 am
agen
Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized
Medium
Report
Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized
3/10
08:11 am
agen
Agenus receives $20M payment under Zydus Life Sciences collaboration [Seeking Alpha]
Medium
Report
Agenus receives $20M payment under Zydus Life Sciences collaboration [Seeking Alpha]
3/10
07:47 am
agen
Agenus Triggers First $20M Contingent Payment Under Zydus Life Sciences Collaboration to Support BOT+BAL Manufacturing Needs [Yahoo! Finance]
Medium
Report
Agenus Triggers First $20M Contingent Payment Under Zydus Life Sciences Collaboration to Support BOT+BAL Manufacturing Needs [Yahoo! Finance]
3/10
07:30 am
agen
Agenus Triggers First $20M Contingent Payment Under Zydus Life Sciences Collaboration to Support BOT+BAL Manufacturing Needs
Medium
Report
Agenus Triggers First $20M Contingent Payment Under Zydus Life Sciences Collaboration to Support BOT+BAL Manufacturing Needs
3/4
04:46 pm
agen
Agenus to Provide Fourth Quarter and Year-end 2025 Financial Report and Corporate Update [Yahoo! Finance]
High
Report
Agenus to Provide Fourth Quarter and Year-end 2025 Financial Report and Corporate Update [Yahoo! Finance]
3/4
04:30 pm
agen
Agenus to Provide Fourth Quarter and Year-end 2025 Financial Report and Corporate Update
High
Report
Agenus to Provide Fourth Quarter and Year-end 2025 Financial Report and Corporate Update
2/24
09:42 am
agen
Agenus (AGEN) Presents New Phase 1b Clinical Data on BOT/BAL Combination for MSS mCRC [Yahoo! Finance]
Medium
Report
Agenus (AGEN) Presents New Phase 1b Clinical Data on BOT/BAL Combination for MSS mCRC [Yahoo! Finance]
2/19
03:15 pm
agen
Agenus Presents Biomarker Data Demonstrating Survival Stratification in MSS mCRC and Other Immunologically Cold Tumors Treated with BOT+BAL
Low
Report
Agenus Presents Biomarker Data Demonstrating Survival Stratification in MSS mCRC and Other Immunologically Cold Tumors Treated with BOT+BAL
2/12
10:11 pm
agen
??????????????????????:?????????2035????1,754?8,000??????????? [CNET News]
Low
Report
??????????????????????:?????????2035????1,754?8,000??????????? [CNET News]
2/9
01:46 pm
agen
Agenus to Present New Data at AACR-IO Exploring Systemic and Tumor Inflammation Biomarkers with BOT/BAL in Immunologically Cold Tumors [Yahoo! Finance]
Low
Report
Agenus to Present New Data at AACR-IO Exploring Systemic and Tumor Inflammation Biomarkers with BOT/BAL in Immunologically Cold Tumors [Yahoo! Finance]